Clinical efficacy of cooling-blood and clearing-stasis methods in treatment of sepsis-induced myocardial dysfunction

Effects of Taohe Chengqi Decoction in ameliorating sepsis-induced myocardial dysfunction: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006553

Enrollment

Unknown

Registered

2022-09-01

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis-induced myocardial dysfunction

Interventions

Treatment group:Taohe Chengqi Decoction

Control group:1/10 Taohe Chengqi Decoction

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: patients who meet the diagnostic criteria of sepsis-induced myocardial dysfunction and TCM syndrome differentiation criteria of stasis and heat; Aged between 18 and 90;

Exclusion criteria

Exclusion criteria: aged 90; pregnant or lactation patients; combined with cardiogenic or hypovolemic shock; metabolic acidosis; chronic renal insufficiency and hospital stay <24h;

Design outcomes

Primary

Measure	Time frame
PCT;TNF-a;IL-10;BNP;Hs-CRP;CKMB;LVEF;cTnI;	—

Secondary

Measure	Time frame
APACHE? score;SOFA score;	—

Countries

China

Contacts

Public ContactZhuang Yan

athena2004112@163.com13912941885

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026